2,852
Views
15
CrossRef citations to date
0
Altmetric
Reviews

The unmet need for pertussis prevention in patients with chronic obstructive pulmonary disease in the Italian context

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 340-348 | Received 07 Jun 2019, Accepted 30 Jul 2019, Published online: 06 Sep 2019

References

  • Kilgore PE, Salim AM, Zervos MJ, Schmitt HJ. Pertussis: microbiology, disease, treatment, and prevention. Clin Microbiol Rev. 2016;29:449–86. doi:10.1128/CMR.00083-15.
  • Pickering LK, Baker CJ, Kimberlin DW. Pertussis (Whooping cough). In: Book R editor. Report of the committee on infectious diseases. 29th ed. Elk Grove Village (IL): American Academy of Pediatrics; 2012. p. 553–66.
  • World Health Organization. Pertussis vaccines: WHO position paper – August 2015. Wkly Epidemiol Rec 2015;90:433–60.
  • Todar K. Bordetella pertussis and whooping cough. Madison (WI): Todar’s Online Textbook of Bacteriology; 2009. [accessed 2018 Nov 21. http://textbookofbacteriology.net/pertussis.html.
  • Paddock CD, Sanden GN, Cherry JD, Gal AA, Langston C, Tatti KM, Wu KH, Goldsmith CS, Greer PW, Montague JL, et al. Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin Infect Dis. 2008;47:328–38. doi:10.1086/589753.
  • Lamberti Y, Gorgojo J, Massillo C, Rodriguez ME. Bordetella pertussis entry into respiratory epithelial cells and intracellular survival. Pathog Disease. 2013;69:194–204. doi:10.1111/2049-632X.12072.
  • Plotkin SA, Orenstein WA, Offit PA. Pertussis vaccines. In: Vaccines 6th ed. Edinburgh (Scotland): Elsevier/Saunders; 2013. p. 447–92.
  • Tozzi AE, Celentano LP, Ciofi Degli Atti ML, Salmaso S. Diagnosis and management of pertussis. CMAJ. 2005;172:509–15. doi:10.1503/cmaj.1040766.
  • De Serres G, Shadmani R, Duval B, Boulianne N, Déry P, Douville Fradet M, Rochette L, Halperin SA. Morbidity of pertussis in adolescents and adults. J Infect Dis. 2000;182:174–79. doi:10.1086/315648.
  • Novak M. Pertussis. In: Garfunkel LC, Kaczorowski JM, Christy C editors. Pediatric clinical advisor. 2nd. Philadelphia (PA): Moby, Inc.; 2002. p. 440–41.
  • de Greeff S, Mooi F, Westerhof A, Verbakel J, Peeters M, Heuvelman CJ, Notermans DW, Elvers LH, Schellekens JF, de Melker HE. Pertussis disease burden in the household: how to protect young infants. Clin Infect Dis. 2010;50:1339–45. doi:10.1086/652281.
  • Tozzi AE, Rosati GV, Ciarrocchi G, Ferrera G, Gabutti G, Giuffrida S, Locuratolo F, Marchetti F, Mereu G, Pellegrino A, et al. Riduzione del rischio di pertosse nel neonato mediante vaccinazione: la strategia cocoon in Italia. Riv Immunol Allergol Pediatr. 2012;2(Suppl 3):1–14.
  • Chiappini E, Stival A, Galli L, de Martino M. Pertussis re-emergence in the post-vaccination era. BMC Infect Dis. 2013;13:151. doi:10.1186/1471-2334-13-151.
  • Centers for Disease Control and Prevention. Pregnancy and Whooping Cough. For Pregnant Women. 2017 Jun 29 [accessed 2019 Jan 28]. https://www.cdc.gov/pertussis/pregnant/mom/index.html.
  • Public Health England. Vaccination against pertussis (Whooping cough) for pregnant women – 2016. Information for healthcare professionals. London (United Kingdom): Government Digital Service, Government of the United Kingdom’s Cabinet Office; 2016. [accessed 2019 Jan 28]. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/529956/FV_JUNE_2016_PHE_pertussis_in_pregnancy_information_for_HP_.pdf.
  • Forsyth KD, Tan T, von König CW, Heininger U, Chitkara AJ, Plotkin S. Recommendations to control pertussis prioritized relative to economies: a global pertussis initiative update. Vaccine. 2018;36:7270–75. doi:10.1016/j.vaccine.2018.10.028.
  • World Health Organization. Chronic obstructive pulmonary disease (COPD). 2018 [accessed 2018 Nov 16]. http://www.who.int/respiratory/copd/en/.
  • Bettoncelli G, Blasi F, Brusasco V, Centanni S, Corrado A, De Benedetto F, De Michele F, Di Maria GU, Donner CF, Falcone F, et al. The clinical and integrated management of COPD. An official document of AIMAR (Interdisciplinary Association for Research in Lung Disease), AIPO (Italian Association of Hospital Pulmonologists), SIMER (Italian Society of Respiratory Medicine), SIMG (Italian Society of General Medicine). Multidiscip Respir Med. 2014;9:25. doi:10.1186/2049-6958-9-25.
  • Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E, Nair H, Gasevic D, Sridhar D, Campbell H, et al. Global and regional estimates of COPD prevalence: systematic review and meta–analysis. J Glob Health. 2015;5:020415. doi:10.7189/jogh.05-020415.
  • Dal Negro R, Rossi A, Cerveri I. The burden of COPD in Italy: results from the confronting COPD survey. Respir Med. 2003;97(Suppl):C:S43-S50. doi:10.1016/S0954-6111(03)80024-0.
  • de Marco R, Pesce G, Marcon A, Accordini S, Antonicelli L, Bugiani M, Casali L, Ferrari M, Nicolini G, Panico MG, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population. PLoS One. 2013;8:e62985. doi:10.1371/journal.pone.0062985.
  • Malhotra R, Olsson H. Immunology, genetics and microbiota in the COPD pathophysiology: potential scope for patient stratification. Expert Rev Respir Med. 2015;9:153–59. doi:10.1586/17476348.2015.1000865.
  • Atamas SP, Chapoval SP, Keegan AD. Cytokines in chronic respiratory diseases. F1000 Biol Rep. 2013;5:3. doi:10.3410/B5-3.
  • Sethi S. Infection as a comorbidity of COPD. Eur Respir J. 2010;35:1209–15. doi:10.1183/09031936.00081409.
  • Hillas G, Perlikos E, Tsiligianni I, Tzanakis N. Managing comorbidities in COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:95–109. doi:10.2147/COPD.S54473.
  • National Heart, Lung, and blood institute. COPD. 2018 [accessed 2018 Nov 21]. https://www.nhlbi.nih.gov/health-topics/copd.
  • Monto AS, Higgins MW, Ross HW. The Tecumseh study of respiratory illness. VIII: acute infection in chronic respiratory disease and comparison groups. Am Rev Respir Dis. 1975;111:27–36. doi:10.1164/arrd.1975.111.1.27.
  • National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health U.S. Department of health and human services. Chapter 4. Respiratory diseases. In: The health consequences of smoking: a report of the surgeon general. Atlanta (GA): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004. p. 421–524.
  • Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet. 2012;379:1341–51. doi:10.1016/S0140-6736(11)60968-9.
  • Feldman C, Anderson R. Cigarette smoking and mechanisms of susceptibility to infections of the respiratory tract and other organ systems. J Infect. 2013;67:169–84. doi:10.1016/j.jinf.2013.05.004.
  • Sajjan US. Susceptibility to viral infections in chronic obstructive pulmonary disease: role of epithelial cells. Curr Opin Pulmon Med. 2013;19:125–32. doi:10.1097/MCP.0b013e32835cef10.
  • Bonhoeffer J, Bär G, Riffelmann M, Soler M, Heininger U. The role of Bordetella infections in patients with acute exacerbation of chronic bronchitis. Infection. 2005;33:13–17. doi:10.1007/s15010-005-4004-9.
  • Hashemi SH, Nadi E, Hajilooi M, Seif-Rabiei MA, Samaei A. High seroprevalence of Bordatella pertussis in patients with chronic obstructive pulmonary disease: a case-control study. Tanaffos. 2015;14:172–76.
  • Buck PO, Meyers JL, Gordon LD, Parikh R, Kurosky SK, Davis KL. Economic burden of diagnosed pertussis among individuals with asthma or chronic obstructive pulmonary disease in the USA: an analysis of administrative claims. Epidemiol Infect. 2017;145:2109–21. doi:10.1017/S0950268817000887.
  • Meyer S, Faulkner A, Miner C, Edge K, Cruz V, Bargsten M, Kudish K, Coleman J, Pradhan E, Thomas S, et al. Pertussis infections in hospitalized patients—United States, 2010–2014. Open Forum Infect Dis. 2016;3(Suppl 1):1752. doi:10.1093/ofid/ofw194.132.
  • Mbayei SA, Faulkner A, Miner C, Edge K, Cruz V, Peña SA, Kudish K, Coleman J, Pradhan E, Thomas S, et al. Severe pertussis infections in the United States, 2011-2015. Clin Infect Dis. 2018. doi:10.1093/cid/ciy889.
  • Chen WH, Kozlovsky BF, Effros RB, Grubeck-Loebenstein B, Edelman R, Sztein MB. Vaccination in the elderly: an immunological perspective. Trends Immunol. 2009;30:351–59. doi:10.1016/j.it.2009.05.002.
  • Lee HJ, Choi JH. Tetanus–diphtheria–acellular pertussis vaccination for adults: an update. Clin Exp Vaccine Res. 2017;6:22–30. doi:10.7774/cevr.2017.6.1.22.
  • Tanriover M, Soyler C, Ascioglu S, Cankurtaran M, Unal S. Low seroprevalance of diphtheria, tetanus and pertussis in ambulatory adult patients: the need for lifelong vaccination. Eur J Intern Med. 2014;25:528–32. doi:10.1016/j.ejim.2014.04.010.
  • Centers for Disease Control and Prevention. Vaccine Information for adults: lung disease including asthma and adult vaccination. 2016 May 2 [accessed 2018 Nov 17]. https://www.cdc.gov/vaccines/adults/rec-vac/health-conditions/lung-disease.html
  • Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease – 2018 report. Fontana (WI): Global Initiative for Chronic Obstructive Lung Disease; 2018 [accessed 2018 Nov 21]. https://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdf.
  • Huang CL, Nguyen PA, Kuo PL, Iqbal U, Hsu YH, Jian WS. Influenza vaccination and reduction in risk of ischemic heart disease among chronic obstructive pulmonary elderly. Comput Methods Programs Biomed. 2013;111:507–11. doi:10.1016/j.cmpb.2013.05.006.
  • Alfageme I, Vazquez R, Reyes N, Muñoz J, Fernández A, Hernandez M, Merino M, Perez J, Lima J. Clinical efficacy of anti-pneumococcal vaccination in patients with COPD. Thorax. 2006;61:189–95. doi:10.1136/thx.2005.043323.
  • Sehatzadeh S. Influenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease (COPD): an evidence-based review. Ont Health Technol Assess Ser. 2012;12:1–64.
  • Liang J, Tiwari T, Moro P, Messonnier N, Reingold A, Sawyer M, Clark TA. Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2018;67:1–44. doi:10.15585/mmwr.rr6702a1.
  • European Centre for Disease Prevention and Control. Pertussis: recommended vaccinations. 2019 [accessed 2019 Jan 28]. https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=3&SelectedCountryIdByDisease=−1.
  • Gonfiantini M, Carloni E, Gesualdo F, Pandolfi E, Agricola E, Rizzuto E, Iannazzo S, Ciofi Degli Atti ML, Villani A, Tozzi AE. Epidemiology of pertussis in Italy: Disease trends over the last century. Euro Surveill. 2014;19:20921. doi:10.2807/1560-7917.ES2014.19.40.20921.
  • Palazzo R, Carollo M, Fedele G, Rizzo C, Rota MC, Giammanco A, Iannazzo S, Ausiello CM. Sero-epidemiology working group. Evidence of increased circulation of Bordetella pertussis in the Italian adult population from seroprevalence data (2012-2013). J Med Microbiol. 2016;65:649–57. doi:10.1099/jmm.0.000264.
  • Piano Nazionale di Prevenzione Vaccinale 2017-2019. Roma (Italy): Ministerio della Salute; 2017 [[accessed 2018 Nov 18]. Italian. http://www.salute.gov.it/imgs/C_17_pubblicazioni_2571_allegato.pdf.
  • World Health Organization. Diphtheria vaccine: WHO position paper – August 2017. Wkly Epidemiol Rec 2017;92:417–35.
  • World Health Organization. Tetanus vaccine: WHO position paper – February 2017. Wkly Epidemiol Rec 2017;92:53–76.
  • Vojtek I, Dieussaert I, Doherty TM, Franck V, Hanssens L, Miller J, Bekkat-Berkani R, Kandeil W, Prado-Cohrs D, Vyse A. Maternal immunization: where are we now and how to move forward? Ann Med. 2018;50:193–208. doi:10.1080/07853890.2017.1421320.
  • Filia A, Bella A, von Hunolstein C, Pinto A, Alfarone G, Declich S, Rota MC. Tetanus in Italy 2001-2010: a continuing threat in older adults. Vaccine. 2014;32:639–44. doi:10.1016/j.vaccine.2013.12.012.
  • Bergamini M, Comodo N, Gasparini R, Gabutti G, Fabrizi P, Severini R, Ajello F, Bonanni P, Castagnari L, Cocchioni M, et al. Prevalence of diphtheria toxin antibodies in human sera from a cross-section of the Italian population. Vaccine. 1999;17:286–90. doi:10.1016/s0264-410x(98)00053-x.
  • Weinberger B, Schirmer M, Matteucci Gothe R, Siebert U, Fuchs D, Grubeck-Loebenstein B. Recall responses to tetanus and diphtheria vaccination are frequently insufficient in elderly persons. PLoS One. 2013;8:e82967. doi:10.1371/journal.pone.0082967.
  • Council conclusions on vaccinations as an effective tool in public health. Brussels (Belgium): Council of the European Union; 2014 [accessed 2018 Nov 18]. http://www.consilium.europa.eu/uedocs/cms_data/docs/pressdata/en/lsa/145973.pdf.
  • Signorelli C, Guerra R, Siliquini R, Ricciardi W. Italy’s response to vaccine hesitancy: an innovative and cost effective national immunization plan based on scientific evidence. Vaccine. 2017;35:4057–59. doi:10.1016/j.vaccine.2017.06.011.
  • Lettera Circolare. Oggetto: Aspetti operativi per la piena e uniforme implementazione del nuovo PNPV 2017-2019 e del relativo Calendario Vaccinale. Roma (Italy): Ufficio 5 - Prevenzione delle malattie trasmissibili e profilassi internazionale, Direzione generale della prevenzione sanitaria, Ministero della Salute; 2017 [accessed 2018 Nov 18]. Italian. http://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2017&codLeg=58583&parte=1%20&serie=null.
  • Centers for Disease Control and Prevention. Whooping Cough (Pertussis) Vaccination. 2017 Nov 28 [accessed 2019 Feb 18]. https://www.cdc.gov/vaccines/vpd/pertussis/index.html.
  • Gallo G, Mel R, Ros E, Filia A. Guida alle controindicazioni alle vaccinazioni. Quinta edizione. Roma (Italy): Consiglio Superiore di Sanità, Ministero della Salute; 2018 [accessed 2019 Feb 22]. Italian. http://www.salute.gov.it/imgs/C_17_pubblicazioni_2759_allegato.pdf.
  • Dati coperture vaccinali. Roma (Italy): Ministerio della Salute; 2018 Jul 16 [accessed 2019 Jul 17]. Italian. http://www.salute.gov.it/portale/temi/p2_6.jsp?id=811&area=Malattie%20infettive&menu=vaccinazioni.
  • Vaccinazione antinfluenzale: stagione 2017‐2018. Coperture vaccinali per 100 abitanti. Roma (Italy): Ministerio della Salute; 2018 Jul 19 [accessed 2019 Jul 17]. Italian. http://www.salute.gov.it/imgs/C_17_tavole_19_allegati_iitemAllegati_0_fileAllegati_itemFile_5_file.pdf.
  • Gramegna A, Dellafiore S, Contarini M, Blasi F, Aliberti S, Tosatto R, Mantero M. Knowledge and attitudes on influenza vaccination among Italian physicians specialized in respiratory infections: an Italian Respiratory Society (SIP/IRS) web-based survey. J Prev Med Hyg. 2018;59:E128–E131.
  • EpiCentro. Il portale dell’epidemiologia per la sanità pubblica. La sorveglianza Passi. I dati per l’Italia, vaccinazione antinfluenzale, 2015-2018. Roma (Italy): Istituto superiore di sanità. [accessed 2019 Jul 17]. Italian. https://www.epicentro.iss.it/passi/dati/VaccinazioneAntinfluenzale.
  • Signorelli C. Andamento delle coperture vaccinali in Italia. Roma (Italy): Società Italiana di Igiene; 2016 [accessed 2019 Jul 17]. Italian. http://www.igienistionline.it/docs/2016/3\igministero.pdf.